Stryker, a global leader in medical technologies, has launched the Trident II Acetabular System in India, strengthening its portfolio in total hip arthroplasty (THA).

Designed to enhance precision, stability and surgical confidence, the system builds on the legacy of Stryker’s Trident brand and incorporates advanced materials such as Tritanium In-Growth Technology and PureFix HA.

The Trident II system has been recognized as the most implanted acetabular shell in the Australian Orthopaedic Association National Joint Replacement Registry for 20 consecutive years.

It offers compatibility with Mako SmartRobotics™, supports diverse surgical approaches, and features the Innerchange Locking Mechanism for intraoperative flexibility and improved joint stability.

“Hip replacement surgeries are rising globally due to ageing populations and rising incidence of osteoarthritis and mobility-related disorders. With the launch of the Trident II Acetabular System, we reinforce our commitment to bringing clinically proven, innovation-led solutions to surgeons and their patients,” said Aman Rishi, Vice President & General Manager, India, Stryker. “By combining advanced materials, data-backed design and robotic-arm assisted capabilities, Trident II represents a significant step forward in hip replacement solutions.”

The system also integrates highly crosslinked polyethylene X3 to improve wear resistance and long-term implant performance.